| Literature DB >> 35890084 |
Sabina Lachowicz-Wiśniewska1,2,3, Anubhav Pratap-Singh3, Ireneusz Kapusta4, Angelika Kruszyńska5, Andrzej Rapak5, Ireneusz Ochmian2, Tomasz Cebulak4, Wioletta Żukiewicz-Sobczak1, Paweł Rubiński1.
Abstract
The present work aims to assess the biological potential of polyphenolic compounds in different parts (flowers, leaves, stems, and roots) of Stachys palustris L. Towards secondary metabolites profile, 89 polyphenolic compounds (PCs) were identified by UPLC-PDA-ESI-TQD-MS/MS, with a total average content of 6089 mg/100 g of dry matter (d.m.). In terms of biological activity, antioxidant activity (radical activity, reducing power), digestive enzyme inhibitory (α-glucosidase, α-amylase, pancreatic lipase) effect, and antiproliferative activity (inhibition of cell viability and induction of apoptosis in different human cancer cell lines) were explored. Leaves, flowers, stems, and roots of S. palustris L. have not been studied in this regard until now. Vescalagin and cocciferin d2, isoverbascoside (verbascoside), luteolin 6-C-glucoside, luteolin 6-C-galactoside, apigenin 6-C-glucoside, (-)-epicatechin, ellagic acid, and malvidin 3-O-diglucoside were detected as main ingredients in the studied parts. Methanolic extract of S. palustris L. leaves and flowers revealed the highest amount of PCs with the strongest antiradical (18.5 and 15.6 mmol Trolox equivalent (TE)/g d.m., respectively) and reducing power effects (7.3 and 5.6 mmol TE/g d.m.). Leaf extracts exhibited better α-amylase and pancreatic lipase inhibition effects, while flower extracts exhibited better α-glucosidase inhibition effect. Regarding antiproliferative activity, extracts of the leaves and flowers significantly reduced cell viability and induced a high level of apoptosis in human lung, pancreatic, bladder, and colon cancer cell lines, as well as in human acute myeloid leukemia; whereas the extracts from stems and roots revealed the weaker effects. The results of this work showed anti-proliferative and potentially anti-diabetic, anti-obesity properties of S. palustris L., especially for flowers and leaves, which may have wide potential applications in the functional food, special food, pharmaceutical, cosmetics industries, and/or in medicine.Entities:
Keywords: bioactive compounds; in vitro biological potency; marsh woundwort; medical plant
Year: 2022 PMID: 35890084 PMCID: PMC9317270 DOI: 10.3390/ph15070785
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Characterization of polyphenolic compounds in Stachys palustris L. by LC–PDA-ESI–TQD–MS/MS.
| Identified Compounds | Rr [min] | Δd | [M-H]−/MS-MS | Ref. |
|---|---|---|---|---|
| Hydrolysable tannins | ||||
| Grandinin | 2.49 | 203 | 1065/975/931/301 | [ |
| Grandinin isomer | 2.71 | 227 | 1065/975/931/301 | [ |
| Grandinin isomer | 2.77 | 203 | 1065/975/931/301 | [ |
| Castalagin/vescalagin isomer | 2.83 | 224 | 933/915/631/301 | [ |
| Vescalagin | 2.93 | 224 | 933/915/631/613/569/467/301 | [ |
| Castalagin/vescalagin isomer | 3.01 | 224 | 933/915/613/569/467/301 | [ |
| Castalagin/vescalagin (HHDP–NHTP–glucose) isomer | 3.25 | 224 | 933/915/889/871/631/613/467/301 | [ |
| Pedunculagin isomer (diHHDP-glucose) | 3.36 | 232 | 783/481/301 | [ |
| Castalagin/vescalagin isomer | 3.43 | 204 | 933/915/889/631/301 | [ |
| Cocciferin d2 isomer | 3.59 | 224 | 933/915/631/301 | [ |
| Castalagin/vescalagin isomer | 3.69 | 204 | 933/631/461/301 | [ |
| Pedunculagin isomer (diHHDP-glucose) | 3.95 | 204 | 783/481/301 | [ |
| Castalagin/vescalagin isomer | 4.02 | 208 | 933/915/631/301 | [ |
| Pedunculagin isomer (diHHDP-glucose) | 4.24 | 230, 275 | 783/481/301 | [ |
| Castalagin/Vescalagin isomer | 4.29 | 245 | 933/915/871/613/569/301 | [ |
| Casuarictin (galloyl-DiHHDP-glucose) | 4.45 | 205 | 935/783/633/301 | [ |
| Cocciferin d2 isomer | 4.51 | 223 | 933/915/631/390/301 | [ |
| Chebulanin | 4.54 | 205 | 651/481/463/337/319/275/169 | [ |
| Castalagin/vescalagin isomer | 4.58 | 212/270 | 933/631/569/301 | [ |
| Chebulanin | 4.60 | 206 | 651/481/463/337/319/275/169 | [ |
| Sanguiin H-10 isome (digalloyltriHHDPdiglucose) | 4.87 | 315 | 1567/1265/1103/933/631/481/301 | [ |
| Castalagin/vescalagin isomer | 4.93 | 216 | 933/633/481/301 | [ |
| Castalagin/Vescalagin isomer | 5.05 | 276/353 | 933/915/871/631/613/467/301 | [ |
| Casuarinin (diHHDP-galloyl-glucose) | 5.18 | 217 | 935/783/633/481/301 | [ |
| Castalagin/vescalagin isomer | 5.33 | 220 | 933/783/633/434/301 | [ |
| Pedunculagin (diHHDP-glucose) | 5.43 | 313 | 783/707/633/481/301 | [ |
| Sanguiin H-10 isomer (digalloyltriHHDPdiglucose) | 5.51 | 240 | 1567/783/631/481/301 | [ |
| Roburin E | 5.63 | 230 | 1064/301 | [ |
| Vescalagin isomer | 5.91 | 218 | 933/631/467/301 | [ |
| Castalagin isomer | 6.16 | 222 | 933/631/467/301 | [ |
| Geraniin isomer | 6.25 | 209 | 951/933/633/301/257 | [ |
| Casuarinin/potentilin (galloyl-diHHDP-glucose) | 6.51 | 279 | 935/783/633/301 | [ |
| Tellimagrandin I (digalloyl-HHDP-glucose) | 6.53 | 218/277 | 785/615/483/301 | [ |
| Pentagalloyl-glucose | 6.95 | 280 | 939/787/769/617/599/447 | [ |
| Tellimagrandin I isomer (digalloyl-HHDP-glucose) | 6.99 | 218/277 | 785/615/483/301 | [ |
| Trigalloyl-HHDP-glucose | 7.07 | 280 | 937/767/635/465/301 | [ |
| Trigalloyl-HHDP-glucose | 7.74 | 280 | 937/767/635/465/301 | [ |
| Trigalloyl-HHDP-glucose | 7.80 | 281 | 937/767/635/465/301 | [ |
| Trigalloyl-HHDP-glucose | 7.93 | 281 | 937/767/635/465/301 | [ |
| Chebulagic acid (galloyl-chebuloyl-HHDP-glucose) | 8.00 | 220/272 | 953/785/633/463/337/301/169 | [ |
| Phenylethanoid glycosides | ||||
| Echinacoside | 6.27 | 329 | 785/623/461/161 | [ |
| Betonyoside E | 6.32 | 326 | 785/639//621/609/193/161 | [ |
| Stachysoside A | 6.38 | 272 | 755/623/461/593/179/161 | [ |
| B-OH-Forsythoside B methylether | 7.29 | 330 | 785/755/623/347/161 | [ |
| Stachysoside A | 7.41 | 330 | 755/623/593/461/179/161 | [ |
| Isoacteoside (isoverbascoside) | 7.60 | 330 | 623/461/161 | [ |
| B-OH-Forsythoside B methylether | 7.80 | 323 | 785/755/623/347/161 | [ |
| Forsythoside B isomer | 7.91 | 330 | 755/623/607/593/461/161 | [ |
| Forsythoside B isomer | 7.97 | 325 | 755/623/593/461/161 | [ |
| Forsythoside B isomer | 8.07 | 326 | 755/623/461/447/161 | [ |
| Cistanoside A | 8.22 | 328 | 799/637/623/475/315 | [ |
| Alyssonoside | 8.34 | 329 | 769/593/575/447/315/161 | [ |
| Alyssonoside isomer | 8.59 | 329 | 769/593/575/447/315/161 | [ |
| Martynoside | 9.34 | 283 | 651/475/457/328/161 | [ |
| Samioside | 10.02 | 329 | 755/593/461/315/161 | [ |
| Leucoseptoside A | 10.29 | 313 | 637/461/315/193/175/161 | [ |
| Stachysoside E | 10.43 | 319 | 669/625/583/380/264 | [ |
| Anthocyanins | ||||
| Delphinidin 3- | 3.65 | 520 | 465/303 | [ |
| Malvidin 3- | 4.51 | 525 | 665/493/331 | [ |
| Cyanidin 3- | 5.06 | 517 | 449/287 | [ |
| Malvidin 3- | 6.00 | 525 | 535/331 | [ |
| Flavan-3-ols | ||||
| (-)Epicatchin | 4.83 | 280 | 289 | [ |
| Phenolic acid | ||||
| Ellagic acid glucoside | 5.74 | 370 | 463/301 | [ |
| Ellagic acid pentoside | 6.05 | 254/362 | 433/301 | [ |
| Ellagic acid | 7.52 | 255/365 | 301 | [ |
| 3,4-dicaffeoyl quinic acid | 8.91 | 324 | 515/353/191/179 | [ |
| 3,5-dicaffeoyl quinic acid | 9.04 | 324 | 515/353/191/179 | [ |
| 4,5-dicaffeoyl quinic acid | 11.07 | 324 | 515/353/191/179 | [ |
| Flavonols | ||||
| Kaempferol hexose glucuronide | 10.85 | 343 | 623/285 | [ |
| Flavones | ||||
| Chrysoeriol acetyl-allopyranosyl-glucopyranoside | 5.82 | 269/332 | 677/299 | [ |
| Luteolin-6-C-galactoside | 6.59 | 269/349 | 447/357/327/297/285 | [ |
| Luteolin-6-C-glucoside | 6.74 | 267/347 | 447/357/327/299/285 | [ |
| Apigenin-6-C-galactoside | 7.29 | 268/336 | 431/341/311/283/269 | [ |
| Apigenin-6-C-glucoside | 7.43 | 269/336 | 431/341/311/283/269 | [ |
| Apigenin 7- | 8.26 | 325 | 577/432/407/269 | [ |
| Apigenin acetyl-allosyl-glucoside | 9.01 | 332 | 635/269 | [ |
| Chrysoeriol 7- | 10.84 | 311 | 667/299 | [ |
| 4′-O-methylisoscutellarein-diacetyl-allosyl-glucopyranoside | 8.62 | 346 | 707/299 | [ |
| 4′-O-methylisoscutellarein-acetyl-allosyl-glucopyranoside | 8.87 | 329 | 665/485/299 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose | 9.19 | 276/330 | 651/429/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.32 | 326 | 651/637/429/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.44 | 329 | 651/607/429/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.49 | 329 | 651/607/429/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.63 | 329 | 651/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.72 | 329 | 651/285 | [ |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | 9.79 | 314 | 651/285 | [ |
| Isoscutellarein-acetylallosyl-glucopyranoside | 9.85 | 328 | 651/285 | [ |
| Isoscutellarein- acetylallosyl-glucopyranoside isommer | 10.10 | 329 | 651/285 | [ |
| 4′- | 11.23 | 277/305 | 665/299 | [ |
Rt, retention time.
Total polyphenol content in different parts of Stachys palustris L. [mg/100 g d.m.].
| Polyphenolic Compounds | Flowers | Leaves | Stems | Roots |
|---|---|---|---|---|
| Hydrolysable Tannins (HT) | ||||
| Grandinin | 172.25 ± 2.07a a | 76.69 ± 0.92b | 62.67 ± 0.75c | 32.34 ± 0.39d |
| Grandinin isommer | 399.62 ± 4.80b | 533.26 ± 6.40a | 230.27 ± 2.76c | nd |
| Grandinin isommer | 265.51 ± 3.19a | nd b | 71.98 ± 0.86c | 120.43 ± 1.45b |
| Castalagin/vescalagin isomer | 214.78 ± 2.58b | 494.02 ± 5.93a | 212.20 ± 2.55b | nd |
| Vescalagin | 2370.75 ± 18.97a | 1528.04 ± 12.22b | 1236.86 ± 9.89c | 403.8 ± 3.23d |
| Castalagin/vescalagin isomer | 36.41 ± 0.44c | 224.02 ± 2.69a | 95.17 ± 1.14b | nd |
| Castalagin/vescalagin (HHDP–NHTP–glucose) isomer | 500.80 ± 6.01a | 129.82 ± 1.56c | 220.30 ± 2.64b | nd |
| Pedunculagin isomer (diHHDP-glucose) | nd | nd | nd | 78.36 ± 0.94a |
| Castalagin/vescalagin isomer | 945.11 ± 1.89b | 1041.14 ± 2.08a | 617.74 ± 1.24c | 51.56 ± 0.62d |
| Cocciferin d2 isomer | 1552.66 ± 18.63a | 1388.25 ± 16.66b | 867.36 ± 10.41c | 230.08 ± 2.76d |
| Castalagin/vescalagin isomer | 636.42 ± 7.64b | 990.62 ± 11.89a | 572.37 ± 6.87c | 37.70 ± 0.45d |
| Pedunculagin isomer (diHHDP-glucose) | 63.94 ± 0.77b | 80.22 ± 0.96a | 27.38 ± 0.33c | 2.59 ± 0.03d |
| Castalagin/vescalagin isomer | 162.72 ± 1.95c | 298.50 ± 3.58a | 137.30 ± 1.65b | 16.72 ± 0.20c |
| Pedunculagin isomer (diHHDP-glucose) | 110.36 ± 1.32b | 143.92 ± 1.73a | 47.51 ± 0.57c | 6.05 ± 0.07d |
| Castalagin/Vescalagin isomer | 100.25 ± 1.20b | 117.42 ± 1.41a | 57.71 ± 0.69c | 13.61 ± 0.16d |
| Casuarictin (galloyl-diHHDP-glucose) | 33.64 ± 0.40b | 85.27 ± 1.02a | 22.76 ± 0.27c | 34.51 ± 0.41b |
| Cocciferin d2 isomer (HHDP-NHTP-glucose-galloyldiHHDP-glucose) | 21.33 ± 0.26b | 29.19 ± 0.35a | 8.57 ± 0.10c | nd |
| Chebulanin | nd | nd | nd | 2.62 ± 0.03a |
| Castalagin/vescalagin isomer | 40.36 ± 0.48a | nd | nd | nd |
| Chebulanin | nd | nd | nd | 12.15 ± 0.15a |
| Sanguiin H-10 isomer (digalloyltriHHDPdiglucose) | 4.73 ± 0.06c | 9.11 ± 0.11b | 3.84 ± 0.05cd | 18.68 ± 0.22a |
| Castalagin/vescalagin isomer | 27.11 ± 0.33a | 28.71 ± 0.34a | 17.43 ± 0.21b | 4.79 ± 0.06c |
| Castalagin/Vescalagin isomer | 18.71 ± 0.22a | 1.32 ± 0.02b | 0.95 ± 0.01b | nd |
| Casuarinin (diHHDP-galloyl-glucose) | 38.79 ± 0.47a | 18.53 ± 0.22b | 7.82 ± 0.09c | 3.42 ± 0.04d |
| Castalagin/vescalagin isomer | 18.55 ± 0.22a | 15.14 ± 0.18b | 8.00 ± 0.10c | 5.39 ± 0.06d |
| Pedunculagin (diHHDP-glucose) | 5.76 ± 0.07b | 11.64 ± 0.14a | 5.43 ± 0.07b | 1.47 ± 0.02c |
| Sanguiin H-10 isomer (digalloyltriHHDPdiglucose) | 8.20 ± 0.10b | 45.22 ± 0.54a | 3.68 ± 0.04c | nd |
| Roburin E | 27.43 ± 0.33a | 20.53 ± 0.25b | 4.11 ± 0.05c | nd |
| Vescalagin isomer | 5.48 ± 0.07c | 8.96 ± 0.11a | 6.31 ± 0.08b | nd |
| Castalagin isomer | 26.95 ± 0.32a | 14.71 ± 0.18b | 4.85 ± 0.06c | 2.54 ± 0.03d |
| Geraniin isomer | 1.63 ± 0.02b | 5.28 ± 0.06a | 4.57 ± 0.05a | nd |
| Casuarinin/potentilin (galloyl-diHHDP-glucose) | nd | 1.39 ± 0.02b | 3.85 ± 0.05a | 1.59 ± 0.02b |
| Tellimagrandin I (digalloyl-HHDP-glucose) | 5.38 ± 0.06a | nd | nd | 2.32 ± 0.03b |
| Pentagalloyl-glucose | 1.83 ± 0.02a | nd | nd | nd |
| Tellimagrandin I isomer (digalloyl-HHDP-glucose) | 5.28 ± 0.06a | nd | nd | nd |
| Trigalloyl-HHDP-glucose | 8.55 ± 0.10a | 4.79 ± 0.06b | 1.94 ± 0.02c | nd |
| Trigalloyl-HHDP-glucose | 6.40 ± 0.08a | 1.30 ± 0.02b | 0.75 ± 0.01c | nd |
| Trigalloyl-HHDP-glucose | 6.23 ± 0.07a | 3.23 ± 0.04b | 0.61 ± 0.01c | nd |
| Trigalloyl-HHDP-glucose | 25.87 ± 0.31a | nd | nd | nd |
| Chebulagic acid (galloyl-chebuloyl-HHDP-glucose) | 75.04 ± 0.90a | 3.33 ± 0.04b | 1.64 ± 0.02c | nd |
| Phenylethanoid glycosides (PhG) | ||||
| Echinacoside | nd | nd | nd | 1.11 ± 0.01a |
| Betonyoside E | 1.53 ± 0.02a | 1.44 ± 0.02a | 0.57 ± 0.01bc | 1.10 ± 0.01b |
| Stachysoside A | 6.62 ± 0.08a | nd | nd | nd |
| B-OH-Forsythoside B methylether | nd | nd | nd | 15.01 ± 0.18a |
| Stachysoside A | nd | nd | nd | 30.72 ± 0.37a |
| Isoacteoside (isoverbascoside) | nd | nd | nd | 114.26 ± 1.37a |
| B-OH-Forsythoside B methylether | nd | nd | nd | 1.04 ± 0.01a |
| Forsythoside B | nd | nd | 5.76 ± 0.07b | 10.84 ± 0.13a |
| Forsythoside B | nd | nd | nd | 1.75 ± 0.02a |
| Forsythoside B isomer | nd | nd | nd | 2.69 ± 0.03a |
| Cistanoside A | nd | nd | nd | 1.33 ± 0.02a |
| Alyssonoside | nd | nd | nd | 13.05 ± 0.16a |
| Alyssonoside isomer | nd | nd | nd | 12.45 ± 0.15a |
| Martynoside | nd | nd | nd | 4.17 ± 0.05a |
| Samioside | nd | nd | nd | 0.92 ± 0.01a |
| Leucoseptoside A | nd | 1.76 ± 0.02a | nd | nd |
| Stachysoside E | nd | 1.70 ± 0.02a | nd | nd |
| Anthocyanins (ANT) | ||||
| Delphinidin 3- | 3.36 ± 0.04a | nd | nd | nd |
| Malvidin 3- | 9.99 ± 0.12a | nd | nd | nd |
| Cyanidin 3- | 3.07 ± 0.04a | nd | nd | nd |
| Malvidin 3- | 3.57 ± 0.04a | nd | nd | nd |
| Flavan-3-ols (F3O) | ||||
| (-)-Epicatchin | 31.95 ± 0.38a | 4.81 ± 0.06c | 13.69 ± 0.16b | nd |
| Phenolic acid (PA) | ||||
| Ellagic acid glucoside | nd | 4.24 ± 0.05a | 0.71 ± 0.01b | nd |
| Ellagic acid pentoside | 5.35 ± 0.06a | 3.56 ± 0.04b | 0.83 ± 0.01c | 0.84 ± 0.01c |
| Ellagic acid | 48.45 ± 0.58a | 26.35 ± 0.32b | 7.18 ± 0.09c | 3.16 ± 0.04d |
| 3,4-dicaffeoyl quinic acid | 0.64 ± 0.01c | 1.41 ± 0.02b | 0.38 ± 0.00c | 21.85 ± 0.26a |
| 3,5-dicaffeoyl quinic acid | 1.98 ± 0.02b | 2.21 ± 0.03a | 1.16 ± 0.01c | 2.03 ± 0.02b |
| 4,5-dicaffeoyl quinic acid | 0.89 ± 0.01a | 0.25 ± 0.00a | 0.30 ± 0.00a | 0.18 ± 0.00a |
| Flavonols (FL) | ||||
| Kaempferol hexose glucuronide | 7.36 ± 0.09a | nd | nd | nd |
| Flavones (FLN) | ||||
| Chrysoeriol acetyl-allopyranosyl-glucopyranoside | nd | 3.86 ± 0.05a | 3.29 ± 0.04a | 1.02 ± 0.01b |
| Luteolin-6-C-galactoside | 22.57 ± 0.27c | 462.91 ± 5.55a | 72.75 ± 0.87b | 0.46 ± 0.01d |
| Luteolin-6-C-glucoside | 45.72 ± 0.55c | 267.68 ± 3.21a | 40.74 ± 0.49b | nd |
| Apigenin-6-C-galactoside | 17.59 ± 0.21c | 237.74 ± 2.85a | 39.72 ± 0.48b | nd |
| Apigenin-6-C-glucoside | 14.16 ± 0.17c | 394.48 ± 4.73a | 65.50 ± 0.79b | nd |
| Apigenin 7- | 1.39 ± 0.02c | 2.70 ± 0.03a | 1.52 ± 0.02b | nd |
| Apigenin acetyl-allosyl-glucoside | nd | nd | nd | 3.72 ± 0.04a |
| Chrysoeriol 7- | nd | 2.01 ± 0.02a | nd | nd |
| 4′-O-methylisoscutellarein-diacetyl-allosyl-glucopyranoside | 36.59 ± 0.44a | 31.61 ± 0.38b | 17.67 ± 0.21c | nd |
| 4′-O-methylisoscutellarein-acetyl-allosyl-glucopyranoside | nd | nd | nd | 5.97 ± 0.07a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose | 0.37 ± 0.00c | 2.96 ± 0.04b | 0.80 ± 0.01c | 93.21 ± 1.12a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 2.91 ± 0.03a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 18.45 ± 0.22a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 11.22 ± 0.13a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 3.58 ± 0.04a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 4.42 ± 0.05a |
| Isoscutellarein-acetylallosyl-(glucopyranoside)apiose isommer | nd | nd | nd | 1.13 ± 0.01a |
| Isoscutellarein-acetylallosyl-glucopyranoside | nd | nd | nd | 5.18 ± 0.06a |
| Isoscutellarein-acetylallosyl-glucopyranoside isommer | nd | nd | nd | 2.69 ± 0.03a |
| 4′- | nd | nd | nd | 14.21 ± 0.17a |
| Procyjanidyny polimery (PP) | 336.61 ± 4.04b | 444.87 ± 5.34a | 102.29 ± 1.23d | 133.55 ± 1.6c |
| Degree of polymerization (DP) | 2.96c | 2.07d | 3.72b | 4.74a |
| The total sum of phenolic compounds | 8544.63b | 9252.11a | 4938.76c | 1622.94d |
a Values that are expressed as the mean (n = 3) ± standard deviation and different letters (between morphological parts) within the same row indicate statistically significant differences by Duncan’s test (p < 0.05); b nd, not identified.
In vitro biological activity.
| Parts of Plant | α-Amylase | α-Glucosidase | Pancreatic Lipase | ABTS | FRAP |
|---|---|---|---|---|---|
| Leaves | 6.85 ± 0.11a a | 12.71 ± 0.20b | 27.46 ± 0.44a | 15.55 ± 0.25b | 7.25 ± 0.12a |
| Flowers | 8.14 ± 0.13b | 11.20 ± 0.18a | 46.23 ± 0.74c | 18.49 ± 0.30a | 5.57 ± 0.09b |
| Stems | 16.43 ± 0.26c | 19.09 ± 0.31c | 38.90 ± 0.62b | 7.81 ± 0.12c | 1.37 ± 0.02c |
| Roots | 26.34 ± 0.42d | 34.81 ± 0.56d | 47.94 ± 0.77c | 4.10 ± 0.07d | 0.39 ± 0.01d |
a Values that are expressed as the mean (n = 3) ± standard deviation and different letters (between morphological parts) within the same row indicate statistically significant differences (p < 0.05).
Figure 1The viability of different cancer cells after treatment with 30% ethanolic extracts for 48 h. One 1:10 solid-to-liquid (S/L) ratio was used for all parts of the plant. Obtained extracts were diluted 30 times to final ethanol concentration 1%.
Figure 2Induction of apoptosis after treatment for 48 h.
Figure 3PCA of bioactive compounds and biological activities for all parts of Stachys palustris L.